Stock info Acadia Pharmaceuticals | Filter  Basic-Info

Stock: Acadia Pharmaceuticals (US broad)

Last Price 21.02 Max Price 21.02
Min Price 21.02 1 Year return 0.00
Sector Health Care Subsector Biotechnology
Annual report 2017

Loading...

Contact info:Street: 11085 Torreyana Road,Suite 100Zip Code: CA 92121City: San DiegoCountry: USAPhone: 858-558-2871Email: info@acadia-pharm.comWebsite: www.acadia-arm.comCEO: Dr. Uli Hacksell Ph.DCFO: Mr. Stephen R. Davis J.D

Sector Review Acadia Pharmaceuticals

Loading...
Year Turnover Total sector Market share
2019 302 135,969 0.22 %
2020 361 152,939 0.24 %
2021 425 227,396 0.19 %
2022 483 260,129 0.19 %
2023 658 214,794 0.31 %

Advice Acadia Pharmaceuticals

No Records Found




News Acadia Pharmaceuticals

No Records Found

Annual reports Acadia Pharmaceuticals

2017 2018 2019 2020 2021

Profile Acadia Pharmaceuticals

Acadia Pharmaceuticals


The past year gave good returns for Acadia Pharmaceuticals investors

Over the period from December 2015 till December 2016 the stock lost around 13 percent. Over the period 2011-2016 the stock rose a massive 2215,08 percent. Acadia Pharmaceuticals's revenues between 2011 and 2015 were far from constant and moved between 4,91 million dollars and 0,06 million dollars. Acadia Pharmaceuticals's net incomes between 2011 and 2015 were very volatile and moved between -22,77 million dollars and -164,44 million dollars.

Acadia Pharmaceuticals has her headquarter located in San Diego. The company mostly operates in the pharmaceutical sector. Acadia Pharmaceuticals is being led by CEO Dr. Uli Hacksell Ph.D. Mr. Stephen R. Davis J.D runs the company as a CFO. The past 10 years the (international) industry gained at around 75 percent. Over the past 5 years the sector is 147 percent higher.

The American company didn't pay out any dividends (in the past 5 years).

Quite a lot of debt Acadia Pharmaceuticals

At the end of 2015 the American company had a balance sheet of 221,9 million dollars. The total debt was around 22,14 million dollars. This is 9,98 percent of the total balance sheet. As per the end of 2015 Acadia Pharmaceuticals's price/earnings-ratio equaled -19. So investors paid for 1 stock -19 times the earnings per share of 2015. Many analysts say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market capitalization (the number of shares times the market price) equaled around 3,49 billion dollars. At the end of 2015 the American company had around 100,63 million stocks listed on the exchanges.

All Acadia Pharmaceuticals's financial reports are available here. More information about Acadia Pharmaceuticals can be found it's website. .


Results Acadia Pharmaceuticals

Results
2015
2016
2017
2018
2019
2020
Revenue
0
16
104
195
302
361
Costs
151
274
345
408
511
591
Profit
-151
-258
-241
-213
-209
-230
Margin of profit
0.0
-1612.50
-231.73
-109.23
-69.21
-63.71
ROI
-82.51
-52.33
-86.38
-51.08
-33.55
-44.83

Balance Acadia Pharmaceuticals

Balance
2015
2016
2017
2018
2019
2020
Equity
183
493
279
417
623
513
Debt
21
40
41
54
75
127
Total assets
204
533
320
471
698
640
Solvency
89.71
92.50
87.19
88.54
89.26
80.16
Cash
198
503
284
412
622
517
Cashflow
-112
-198
-181
-146
-134
-111
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-5.33
-4.95
-4.41
-2.70
-1.79
-0.87

Details Acadia Pharmaceuticals

Details
2016
2017
2018
2019
2020
Price
35.65
28.84
30.11
16.17
42.78
Eps
-2.00
-1.00
-1.00
-1.00
-1.00
Price/earnings-ratio
-17.82
-28.84
-30.11
-16.17
-21.02
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
4.06
2.24
2.90
4.01
3.21
Market to book
0.11
0.08
0.10
0.25
0.15
Cashflow per stock
-1.63
-1.45
-1.01
-0.86
-0.70
Stocks
121
124
144
155
160
Market Cap
4.326.74
3.588.00
4.331.44
2.510.80
3.355.59

Dividend Acadia Pharmaceuticals


Price info Acadia Pharmaceuticals

Date
Price
09 Jul 2025
21.02